Trial intelligence / Profile preview

Azelaic Acid for Demodex in Rosacea

NCT03035955Phase 3Completed

Sponsor
Wake Forest University
Start
Dec 2010
Primary completion
Feb 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of azelaic acid 15% gel vehicle in papulopustular rosacea, sponsored by Wake Forest University. Started Dec 2010; status: completed.

02

Drugs

azelaic acid 15% gel vehicle
03

Conditions

papulopustular rosacea

Beyond the preview

Go deeper on NCT03035955.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03035955.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call